Merial has released the results of a survey - carried out in conjunction with VetSurgeon.org - into the use of nutraceuticals for the management of canine joint problems.

The company says the total market for nutraceutical products remains strong, holding a value of £8.9 million* in the UK, and that this indicates that despite increasing economic pressures, nutraceuticals are still valued by veterinary surgeons and owners as an important part of the management approach to canine joint disease.

The survey generated 163 responses. Results showed that whilst 58% of canine patients with joint health problems received only NSAIDs for treatment, 28% of patients received both NSAIDs and a joint health nutraceutical and 14% received a nutraceutical alone, demonstrating the importance that veterinary practitioners place on the use of nutraceuticals. The survey also showed that on average, UK vets stock and recommend at least two nutraceutical products.

Supleneo flex Product Manager Claire Edmunds said: “This eshot survey yielded some interesting results and the email received the second highest recorded opening rate this year, indicating that it is a topic of great interest. The survey confirmed that vets are actively recommending nutraceuticals, alongside NSAIDs, for canine patients with joint health problems. These data also show that the market remains stable as the level of dispensing correlates well with our previous research. To encourage even more growth in this sector and support the launch of Supleneo flex we have produced a range of support materials, including the provision of samples, money off next purchase vouchers and a loyalty programme. In this way we can continue to support vets in their management of canine joint problems.”

For more information call Merial on 0870 6000 123 or contact your Territory Manager. 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.